Bixiye
Tezspire® (tezepelumab-ekko) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Natiijooyinka Raadinta
Soo bandhiga 1441 - 1450 ee natiijooyinka 3686
Bixiye
QP46-23 Clarification to Preventive Visit Reimbursement Policy (Bulletin P19-23)
Taariikhda uu dhaqangalayo Barnaamijka: May 24, 2023
Bixiye
QP26-23 Healthy Rewards Member Incentive Program for all Blue Plus PMAP & MNCare Members
Taariikhda uu dhaqangalayo Barnaamijka: May 24, 2023
Bixiye
QP45-23 Expansion of SmartChoice Program for Fully Insured Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: May 24, 2023
Bixiye
P46-23 Services Removed from the Commercial Prior Authorization List
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Bixiye
P23R1-23 Laboratory Services: Lab Rebundling Reimbursement Policy will not be Updated
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2023
Bixiye
P31-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective July 3, 2023
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023
Bixiye
P32-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Musculoskeletal Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2023